• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Baxter International

Baxter International

PIMCO All Asset All Authority Inst PAUIX 3 Star

Last Price$8.54Day Change (%)0.23%
Open Price$8.54Day Change ($)0.02
Day Range8.54–8.5452-Week Range7.25–8.77

As of Wed 01/17/2017 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer

    Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer

  2. Fluid Management Systems Market - Product, Disposables and Accessories, & Application - Forecast to 2021 - Research and Markets

    Fluid Management Systems Market - Product, Disposables and Accessories, & Application - Forecast to 2021 - Research and Markets

  3. Baxter's Spin-Off Strategy Is Promising

    Although 2015 may be rocky, both Baxter and Baxalta should see significant margin expansion and growth in the long term, says Morningstar's Karen Andersen.

  4. Medicated Skin Care Products - Global Strategic Business Report 2016-2022: Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth - Research and ...

    Medicated Skin Care Products - Global Strategic Business Report 2016-2022: Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth - Research and Markets

  5. Moats and Growth Drivers Look Solid for Post-Split Baxter

    Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.

  6. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  7. Strong Pipeline Helps Protect Baxter's Wide Moat From Competition

    The diversified health-care firm remains remarkably profitable in tough industries.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.